There’s a quiet revolution happening deep in the anatomy that doesn’t start with robotics or AI-assisted navigation, but with something far more fundamental: materials. The push toward miniaturized medical devices, especially in vascular intervention, isn’t just about making things smaller but also making devices that can be efficacious in the small anatomy.
This is the frontier: the convergence of polymer innovation, extrusion engineering and micron-level quality assurance. It’s how today’s interventional devices are finding their way into narrower, deeper, more tortuous pathways to deliver life enhancing solutions while still achieving the precision and outcomes medical teams rely on.
Material Selection
Miniaturization isn’t new, but the stakes are changing. Treating smaller, more complex vascular anatomies (think cerebral vessels) requires devices with ultra-thin walls, high dimensional precision and gradual durometer transitions along their shaft length. For example, a catheter might start rigid at the proximal end (thus improving pushability) so the surgeon can deliver it, and finish with a soft, atraumatic tip that won’t damage the fragile vessel.
The thinner the walls, the less room there is for error. Even minor material inconsistencies can translate into major mechanical failures like kinks, collapses or pushability loss. It’s not enough to be flexible or strong. Devices must be both simultaneously, and function in micro-space.
Here, materials matter more than ever. Most miniaturized devices are still built from a familiar core of materials: Pebax®, thermoplastic polyurethanes (TPUs like Lubrizol’s Pellethane ® or Carbothane® that bring the ideal mix of flexibility, durability and biocompatibility), nylon blends, as well as some specialty copolymers. These materials have decades of biocompatibility data, predictable processing characteristics and well-understood mechanical behavior.
Pebax is a thermoplastic elastomer prized for its balance of softness and strength, light weight, processability and availability in a wide durometer range. It is a top choice for catheter shafts and balloons and also plays well in multi-durometer constructions.
TPUs are known for balancing elasticity with toughness and biocompatibility. Often used in soft-tip applications and flexible device regions, they can be engineered to hit ultra-low durometer targets. Their low modulus allows delicate vessel navigation while still providing the structural integrity needed for microdelivery systems.
Nylon blends tend to be more rigid than TPUs or Pebax, contributing structural strength and dimensional stability where they’re needed, such as for the proximal sections of catheters or semi-compliant balloons.
Specialty polymers, as well as those that contain custom-blended materials, are tuned for niche properties like lubricity, radiopacity or antimicrobial resistance.
Most material decisions are rooted in predicate devices, known chemistries and a deep preference to replicate what is both familiar and proven. Teams often arrive with a short list already in hand: They know what’s worked in the past, what’s been cleared by regulators and what works with the rest of their system. But familiarity doesn’t mean stagnation. Instead, it creates a launchpad for innovation. Engineers ask, “Can we go thinner? Softer? Stronger?” within the guardrails of materials, processes and vendors they trust. It’s in these nuanced tweaks and targeted substitutions that meaningful performance gains are unlocked. And that’s where materials science starts becoming strategic.
Design for Manufacturability
Even if the right material is chosen, it doesn’t necessarily mean that the tube can be extruded. Stacking dimensions for features like multiple lumens, braiding, tolerances, wall thickness or durometer gradients may look feasible in CAD, but that doesn’t mean the extrusion can be manufactured.
Design for manufacturability (DFM) has become its own discipline in miniaturized device development, looking closely at tolerance stacking, surface finish requirements, wall uniformity and dimensions. For advanced micro-delivery systems, manufacturing is where ideas become real, and precision extrusion, particularly for multi-lumen configurations, is the linchpin of miniaturization.
At most extrusion manufacturers, the tooling is designed in-house and engineered specifically for each part. Just because a tool works for one material, it may not necessarily work for another due to differences in flow dynamics. This is where tooling design and processing know-how make the difference between success and failure.
Braiding and reinforced tubing add another layer of engineering. Wire size, alloy type, fiber strength and geometry all dictate how, for instance, a catheter shaft will perform in terms of pushability, torque or kink resistance. But every choice comes with trade-offs. A tighter braid might improve torque transmission but work against flexibility, while a softer alloy may aid flexibility but impair fatigue resistance. Reinforcement is about balancing mechanics with manufacturability, all inside a finite footprint.
Creating Production Consistency
Of course, it’s one thing to create a perfect prototype but another to produce 10,000 identical units with tight tolerances lot after lot, shift after shift. Variations in resin batches, environment or operator inputs can derail consistency if systems aren’t built for control, and this is why precision extrusion relies on disciplined process validation, data logging, tight-loop feedback systems and operator expertise that’s measured in years or decades.
And it’s not just tubes. Assembly processes have had to evolve alongside the materials, especially for devices with laminated shafts, multiple durometers or embedded functionalities like sensors or pull wires. The bonding method alone can determine a successful or failed assembly. On the other hand, laser bonding can offer pinpoint precision and cleaner joints but demands tight thermal control and material compatibility.
Then there’s the workflow itself: Manual assembly gives flexibility for early-stage iteration or low-volume runs, while semi-automated setups improve consistency and throughput, but require more up-front validation and investment. These choices impact quality assurance protocols, yield rates, design verification testing and ultimately, cost. In miniature devices, where every joint, taper and seal is exhaustively scrutinized, assembly is a critical pillar of performance.
Even inspection and quality assurance must scale with this complexity by proving statistical confidence and demonstrating lot-to-lot repeatability. OEMs routinely request validation samples across multiple shifts, different extrusion lines, different resin lots and even different machine operators to try to simulate the full spectrum of variability.
A Game of Endurance
The route from concept to commercial device can be a marathon measured in years, especially in novel and critical applications. Yet even within those long cycles, the first 12 to 24 months are crucial. A design that gets traction early, from clinician buy-in to preliminary trial data to a solid regulatory strategy, can move to production quickly.
Miniaturization resets how certain medical devices are imagined, built and delivered. And while software, robotics and data all play critical roles, it’s the humble polymer and the disciplined extrusion process that often make or break the device.
Lubrizol’s teams are structured to support every phase of the launch cycle: material formulation, development and design for manufacturability, process validation, regulatory support, production scaling and post launch optimization. It’s not a one-size-fits-all model but a long-term relationship built on engineering trust, product quality and adaptability.
Ultimately, the interplay between manufacturability, processability, precision and polymer science will only intensify. The future of medical devices won’t be built in the spotlight, but in quiet, controlled environments where the right material, in the right device, for the right application, can improve healthcare.
For instance, engineers envision the possibility of a single continuous shaft where different materials transitions seamlessly from stiff-to-soft without having to perform manual assembly to construct the shaft. We’re not there yet, but hybrid constructions, laminated builds and gradient durometer assemblies are getting closer. It’s challenging, but it’s happening slowly and carefully.
What’s emerging isn’t just functional convergence, it’s smart partnerships and co-development: OEMs working more closely with extrusion partners, designers sitting down with polymer scientists, and tooling engineers guiding DFM reviews.
This is where the breakthroughs happen. Not in isolation, but in collaboration.
This article was written by Apur Lathiya, Director of Global Marketing Medical Devices at Lubrizol. He has more than two decades of leadership in precision thermoplastics and medical device manufacturing. For more information, contact Lathiya at
